Consolidated Statements of Operations - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017
Revenues
Products	$ 1,135	$ 535
Services	2,621	3,400
Total Revenues	3,756	3,935
Cost of Revenues
Products	490	494
Services	586	738
Total Cost of Revenues	1,076	1,232
Gross Profit	2,680	2,703
Operating Expenses
Research and development	1,231	964
Sales and marketing	1,726	2,367
General and administrative	14,149	10,874
Acquisition related costs	108	5
Impairment of goodwill	636	587
Amortization of intangibles	3,232	2,936
Total Operating Expenses	21,082	17,733
Loss from Operations	(18,402)	(15,030)
Other Income (Expense)
Interest expense	(1,241)	(1,884)
Change in fair value of derivative liability	48	555
Gain on the sale of Sysorex Arabia	23
Extinguishment loss for debt modification		(653)
Other income/(expense)	(211)	(1,069)
Total Other Income (Expense)	(1,381)	(3,051)
Net Loss from Continuing Operations	(19,783)	(18,081)
Loss from Discontinued Operations, Net of Tax	(4,778)	(16,949)
Net Loss	(24,561)	(35,030)
Net Income/(Loss) Attributable to Non-controlling Interest	11	(17)
Net Loss Attributable to Stockholders of Inpixon	(24,572)	(35,013)
Deemed dividend to preferred stockholders	(6,407)	(756)
Deemed dividend for triggering of warrant down round feature	(13,645)
Net Loss Attributable to Common Stockholders	$ (44,624)	$ (35,769)
Net Loss Per Basic and Diluted Common Share
Loss from continuing operations	$ (51.62)	$ (2,902.47)
Loss from discontinued operations	(6.19)	(2,611.56)
Net Loss Per Share - Basic and Diluted	$ (57.83)	$ (5,511.40)
Weighted Average Shares Outstanding
Basic and Diluted	771,688	6,490